chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: This was a medication administration error attributed to parental (parents are separated/divorced) miscommunication and a medical records issue. There were no adverse events noted, and patient was observed for 30 minutes instead of 15 after shot administration and discovery of error.  Patient arrived at clinic with his mother as guardian. Patient and mother verbally verified more than once that this was the patient's first dose of the Pfizer vaccine. Patient's paperwork from registration process confirmed the first dose. Patient did not have a CDC vaccination record with him.  Once shot was administered and record was being entered into the database, the patient's medical record number indicated that this was, in fact, his second shot.  Database indicated that first shot was administered on 01/22/2022 (Pfizer lot #FK9729, mfg exp 05/2022). Second dose was administered today, 02/01/2022 (actual second dose given on FEBRUARY 1...but it is January 31 in the contiguous (Pfizer lot #FK9729, mfg exp 05/2022).
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Paralysis
Clinical narrative: WITHIN 4 TO 6 WEEKS AFTER 1ST SHOT, EXPERIENCED TINGLING, PRICKING SENSATIONS IN ISOLATED AREAS OF BODY OR ACROSS ENTIRE BODY FOLLOWED BY A SHORT PERIOD OF PARALYSIS (LESS THAN ONE MINUTE). THESE RE-OCCURRED EVERY 1 TO 2 WEEKS UP TO THE PRESENT DATE. AT TIMES, SUSPECTED THAT THEY MAY HAVE COINCIDED WITH NIGHTLY STATIN PILL WHICH WERE TYPICALLY ASSOCIATED WITH "HOT FLASH" SIDE EFFECT ACROSS ENTIRE BODY. NO TREATMENT EXCEPT FOR OCCASSIONALLY SUSPENDING STATIN PILLS FOR SHORT PERIODS.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Bacteraemia, Blood glucose increased, Brain natriuretic peptide increased, COVID-19
Clinical narrative: Received J&J on 4/8/21 and 11/17/21. hospitalized for bacteremia and complicated UTI, was discharged to the nursing home with 7 day course of Rocephin .Apparently she has been having shortness of breath.  On 1/20/21 she tested positive to COVID 19.  On 1/21/22 she was brought to the ED due to worsening shortness of breath. In the ED patient was noted to be hypoxic placed on BiPAP currently on 40% FiO2. There is some concern about COVID-19 pneumonia patient was started on a remdesivir and Decadron.  Also started on empiric antibiotic.  Lasix was used due to concern about slightly elevated BNP and diastolic congestive heart failure Patient was started on Decadron which lead to significant elevation in blood sugar, despite increasing her doses of insulin.  Since patient was off oxygen for last 3 days, Decadron was discontinued due to serious side effect. Patient's back to baseline.  She is advised to go on a CPAP every night.  Discussed with husband.  Husband was going to drop the CPAP machine at nursing home. I return multiple information the chart to make sure that PCP follows the blood sugar closely in case patient developed problem with the hypoglycemia. Appropriate detail instructions return in the discharge. Discharged on 1/28/22.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Dyspnoea, Hypoxia, Left ventricular failure, Lung opacity
Clinical narrative: Received J&J on 4/8/21 and 11/17/21. hospitalized for bacteremia and complicated UTI, was discharged to the nursing home with 7 day course of Rocephin .Apparently she has been having shortness of breath.  On 1/20/21 she tested positive to COVID 19.  On 1/21/22 she was brought to the ED due to worsening shortness of breath. In the ED patient was noted to be hypoxic placed on BiPAP currently on 40% FiO2. There is some concern about COVID-19 pneumonia patient was started on a remdesivir and Decadron.  Also started on empiric antibiotic.  Lasix was used due to concern about slightly elevated BNP and diastolic congestive heart failure Patient was started on Decadron which lead to significant elevation in blood sugar, despite increasing her doses of insulin.  Since patient was off oxygen for last 3 days, Decadron was discontinued due to serious side effect. Patient's back to baseline.  She is advised to go on a CPAP every night.  Discussed with husband.  Husband was going to drop the CPAP machine at nursing home. I return multiple information the chart to make sure that PCP follows the blood sugar closely in case patient developed problem with the hypoglycemia. Appropriate detail instructions return in the discharge. Discharged on 1/28/22.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Received J&J on 4/8/21 and 11/17/21. hospitalized for bacteremia and complicated UTI, was discharged to the nursing home with 7 day course of Rocephin .Apparently she has been having shortness of breath.  On 1/20/21 she tested positive to COVID 19.  On 1/21/22 she was brought to the ED due to worsening shortness of breath. In the ED patient was noted to be hypoxic placed on BiPAP currently on 40% FiO2. There is some concern about COVID-19 pneumonia patient was started on a remdesivir and Decadron.  Also started on empiric antibiotic.  Lasix was used due to concern about slightly elevated BNP and diastolic congestive heart failure Patient was started on Decadron which lead to significant elevation in blood sugar, despite increasing her doses of insulin.  Since patient was off oxygen for last 3 days, Decadron was discontinued due to serious side effect. Patient's back to baseline.  She is advised to go on a CPAP every night.  Discussed with husband.  Husband was going to drop the CPAP machine at nursing home. I return multiple information the chart to make sure that PCP follows the blood sugar closely in case patient developed problem with the hypoglycemia. Appropriate detail instructions return in the discharge. Discharged on 1/28/22.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, Fatigue, Heart rate decreased, Pericarditis
Clinical narrative: Fatigue, appears to be due  decreased heart rate.  Resting heart rate declined approximately 10 BPM between 12/7/2021 and 12/9/2021.  This was detected with a fitness tracker and confirmed with another tracked, a finger OX/BP meter and cuff BP meter over the course of multiple weeks.   Condition resolved after approximately 3 weeks and treatment with NSAIDS.  Dr said Bradycardia was likely due to Pericarditis.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Headache, Hypertension, Malaise, Peripheral swelling
Clinical narrative: Patient reports swelling in her arm, starting the evening of her vaccination.  Her arm had a puffy, raised, red patch covering most of her shoulder.   She had a headache and checked her blood pressure.   She reports it was 157/93, higher than normal for her.  She also said she felt like her blood sugar was low but did not report testing it.  She continued to feel ill off and on but reports feeling better with time.  Her arm today (Monday) still had a red raised patch spanning several inches acrossed her deltoid.  She said it itches but looks better than it had on Saturday evening.  She has not taken any medication during this time.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Skin swelling
Clinical narrative: Patient reports swelling in her arm, starting the evening of her vaccination.  Her arm had a puffy, raised, red patch covering most of her shoulder.   She had a headache and checked her blood pressure.   She reports it was 157/93, higher than normal for her.  She also said she felt like her blood sugar was low but did not report testing it.  She continued to feel ill off and on but reports feeling better with time.  Her arm today (Monday) still had a red raised patch spanning several inches acrossed her deltoid.  She said it itches but looks better than it had on Saturday evening.  She has not taken any medication during this time.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Angina pectoris, Breast pain, Chest discomfort, Dyspnoea
Clinical narrative: Throat swelling, Lip swelling, Shortness of breath, Chest tightness, Rash on both forearms, Pain in area by heart, pain in both breasts and ovary areas, headaches. Family Dr prescribed hydroxychloroquine, steroid and zinc. Continued throat swelling, chest tightness, pains in breasts, ovary areas and heart.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lip swelling, Pharyngeal swelling, Rash, Ultrasound scan
Clinical narrative: Throat swelling, Lip swelling, Shortness of breath, Chest tightness, Rash on both forearms, Pain in area by heart, pain in both breasts and ovary areas, headaches. Family Dr prescribed hydroxychloroquine, steroid and zinc. Continued throat swelling, chest tightness, pains in breasts, ovary areas and heart.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Whip-like rash and itching all over body.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Urticaria
Clinical narrative: Hives on torso and arms. Weakness in arm and leg on side of injection
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Neuralgia, Neuropathy peripheral
Clinical narrative: Neuropathy feet/hands/elbows, nerve pain everywhere, especially in neck. Symptoms still persist 6+ months out
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: patient developed tingling sensation in fingers and feet
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness, Dizziness, Fatigue, Headache, Hypertension
Clinical narrative: Date of Vaccination: 12/10/2021, 3:30 PM  Date Adverse Event Started: 12/10/2021, 3:40 PM  Allergies: Clindamycin, Celebrex, Theraflu, Gabapentin, Polysorbate 80  Medications: Nortriptyline,  Imitrex, Percocet, Klonopin, Testosterone, DHEA, Pregnenalone, Finasteride, Flonase, Medical Marijuana, Levsin, Compazine, Flexeril, Nystatin, Diazepam, Omeprazole, Famotidine, Metoprolol, Melatonin, 5-HTP, Ibuprofen, Acateminophen, Benadryl, Excedrin Migraine, Lidocaine Pathes, Salt Capsules, Vitamin D, Magnesium Malate  Chronic Conditions: Ehlers-Danlos Syndrome (Hypermobility Type), Postural Orthostatic Tachycardia Syndrome, Migraines/Chronic Vestibular Migraine   I received my Moderna COVID-19 booster shot on 12/10/2021. I had received my first two doses of the same Moderna vaccine on 3/9/2021 and 4/6/2021; those both gave me extraordinary pain, muscles aches, headache, fever, and fatigue for about 48 hours, but then the symptoms started calming down. After a week or so, I was back to normal.  I had those same reactions after the booster shot, but even more intensely. Those symptoms did resolve after a week or so. This time, however, beginning just 10 minutes after the shot, I developed the most extreme dizziness and light sensitivity that I have ever experienced.  The nurse took my blood pressure, which was 150/100 ? the highest it has ever been. I have struggled with dizziness and what we suspect are chronic vestibular migraines since September 2013, but never of this intensity. The dizziness began to subside after a few days, but then came back even stronger ten days after the shot on 12/20/2021, and unfortunately the elevation in dizziness has stayed with me ever since. I can barely look at screens, I can?t watch videos if the camera is in motion, and even changes in temperature are enough to render me incapacitated for hours at a time.  Then on 12/23/2021 ? 13 days after the shot ? I woke up with profound tinnitus in both ears. This is the second time this has happened, the first being in 2015, which was suspected at the time to be Autoimmune Inner Ear Disease. Fortunately that abated over time, however, and I never had a severe episode like that again until now. I went to the ENT immediately on 12/23/2021, and my hearing test showed that I had diminished hearing in both ears, particularly in the upper frequencies (which is where my tinnitus was as well; prior tinnitus had all been at lower frequencies). The hearing loss in the right ear was far worse than the left, however, and an Auditory Brainstem Response test showed slowing on the right side compared to the left. I am a professional musician and composer, so this severe tinnitus (accompanied by hyperacusis) has prevented me from doing any of my work in the six weeks that have passed since.  I was put on 60 mg prednisone every day for two weeks, with a 15-day taper after that. This recovered some, but not much, of the hearing loss in my left ear, but not in my right ear. And I continue to have debilitating dizziness, tinnitus, and hyperacusis to this day.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis, Myalgia, Pain, Photophobia, Pyrexia
Clinical narrative: Date of Vaccination: 12/10/2021, 3:30 PM  Date Adverse Event Started: 12/10/2021, 3:40 PM  Allergies: Clindamycin, Celebrex, Theraflu, Gabapentin, Polysorbate 80  Medications: Nortriptyline,  Imitrex, Percocet, Klonopin, Testosterone, DHEA, Pregnenalone, Finasteride, Flonase, Medical Marijuana, Levsin, Compazine, Flexeril, Nystatin, Diazepam, Omeprazole, Famotidine, Metoprolol, Melatonin, 5-HTP, Ibuprofen, Acateminophen, Benadryl, Excedrin Migraine, Lidocaine Pathes, Salt Capsules, Vitamin D, Magnesium Malate  Chronic Conditions: Ehlers-Danlos Syndrome (Hypermobility Type), Postural Orthostatic Tachycardia Syndrome, Migraines/Chronic Vestibular Migraine   I received my Moderna COVID-19 booster shot on 12/10/2021. I had received my first two doses of the same Moderna vaccine on 3/9/2021 and 4/6/2021; those both gave me extraordinary pain, muscles aches, headache, fever, and fatigue for about 48 hours, but then the symptoms started calming down. After a week or so, I was back to normal.  I had those same reactions after the booster shot, but even more intensely. Those symptoms did resolve after a week or so. This time, however, beginning just 10 minutes after the shot, I developed the most extreme dizziness and light sensitivity that I have ever experienced.  The nurse took my blood pressure, which was 150/100 ? the highest it has ever been. I have struggled with dizziness and what we suspect are chronic vestibular migraines since September 2013, but never of this intensity. The dizziness began to subside after a few days, but then came back even stronger ten days after the shot on 12/20/2021, and unfortunately the elevation in dizziness has stayed with me ever since. I can barely look at screens, I can?t watch videos if the camera is in motion, and even changes in temperature are enough to render me incapacitated for hours at a time.  Then on 12/23/2021 ? 13 days after the shot ? I woke up with profound tinnitus in both ears. This is the second time this has happened, the first being in 2015, which was suspected at the time to be Autoimmune Inner Ear Disease. Fortunately that abated over time, however, and I never had a severe episode like that again until now. I went to the ENT immediately on 12/23/2021, and my hearing test showed that I had diminished hearing in both ears, particularly in the upper frequencies (which is where my tinnitus was as well; prior tinnitus had all been at lower frequencies). The hearing loss in the right ear was far worse than the left, however, and an Auditory Brainstem Response test showed slowing on the right side compared to the left. I am a professional musician and composer, so this severe tinnitus (accompanied by hyperacusis) has prevented me from doing any of my work in the six weeks that have passed since.  I was put on 60 mg prednisone every day for two weeks, with a 15-day taper after that. This recovered some, but not much, of the hearing loss in my left ear, but not in my right ear. And I continue to have debilitating dizziness, tinnitus, and hyperacusis to this day.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Temperature intolerance, Tinnitus, Visual impairment
Clinical narrative: Date of Vaccination: 12/10/2021, 3:30 PM  Date Adverse Event Started: 12/10/2021, 3:40 PM  Allergies: Clindamycin, Celebrex, Theraflu, Gabapentin, Polysorbate 80  Medications: Nortriptyline,  Imitrex, Percocet, Klonopin, Testosterone, DHEA, Pregnenalone, Finasteride, Flonase, Medical Marijuana, Levsin, Compazine, Flexeril, Nystatin, Diazepam, Omeprazole, Famotidine, Metoprolol, Melatonin, 5-HTP, Ibuprofen, Acateminophen, Benadryl, Excedrin Migraine, Lidocaine Pathes, Salt Capsules, Vitamin D, Magnesium Malate  Chronic Conditions: Ehlers-Danlos Syndrome (Hypermobility Type), Postural Orthostatic Tachycardia Syndrome, Migraines/Chronic Vestibular Migraine   I received my Moderna COVID-19 booster shot on 12/10/2021. I had received my first two doses of the same Moderna vaccine on 3/9/2021 and 4/6/2021; those both gave me extraordinary pain, muscles aches, headache, fever, and fatigue for about 48 hours, but then the symptoms started calming down. After a week or so, I was back to normal.  I had those same reactions after the booster shot, but even more intensely. Those symptoms did resolve after a week or so. This time, however, beginning just 10 minutes after the shot, I developed the most extreme dizziness and light sensitivity that I have ever experienced.  The nurse took my blood pressure, which was 150/100 ? the highest it has ever been. I have struggled with dizziness and what we suspect are chronic vestibular migraines since September 2013, but never of this intensity. The dizziness began to subside after a few days, but then came back even stronger ten days after the shot on 12/20/2021, and unfortunately the elevation in dizziness has stayed with me ever since. I can barely look at screens, I can?t watch videos if the camera is in motion, and even changes in temperature are enough to render me incapacitated for hours at a time.  Then on 12/23/2021 ? 13 days after the shot ? I woke up with profound tinnitus in both ears. This is the second time this has happened, the first being in 2015, which was suspected at the time to be Autoimmune Inner Ear Disease. Fortunately that abated over time, however, and I never had a severe episode like that again until now. I went to the ENT immediately on 12/23/2021, and my hearing test showed that I had diminished hearing in both ears, particularly in the upper frequencies (which is where my tinnitus was as well; prior tinnitus had all been at lower frequencies). The hearing loss in the right ear was far worse than the left, however, and an Auditory Brainstem Response test showed slowing on the right side compared to the left. I am a professional musician and composer, so this severe tinnitus (accompanied by hyperacusis) has prevented me from doing any of my work in the six weeks that have passed since.  I was put on 60 mg prednisone every day for two weeks, with a 15-day taper after that. This recovered some, but not much, of the hearing loss in my left ear, but not in my right ear. And I continue to have debilitating dizziness, tinnitus, and hyperacusis to this day.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient hospitalized.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Fatigue, Intensive care, Interchange of vaccine products, Vaccination complication
Clinical narrative: Patient came in today and wanted a booster dose. She did report to us that she had severe reaction with the Janssen (JJ) covid vaccine. She said she was hospitalized in the ICU for 3 days. She had severe Fatigue and sedation  amongst other side effects  with the JJ, vaccine that is why she wanted the Moderna Vaccine instead today.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient hospitalized.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blindness unilateral, Echocardiogram, Electrocardiogram, Fatigue
Clinical narrative: headACHE and stomach tired since 1/12  1/26 lost vision right eye 30min headache was seen in er
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Laboratory test, Magnetic resonance imaging head, Scan with contrast, Ultrasound kidney
Clinical narrative: headACHE and stomach tired since 1/12  1/26 lost vision right eye 30min headache was seen in er
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Case was given the wrong type of COVID vaccine.  Case was given Moderna instead of Pfizer booster.   No side effects were noted.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient's guardian requested if Moderna vaccine could be administered instead of Pfizer. Guardian was unaware of age requirement (18). Patient is 14. RPh did not review age requirements and administered Moderna instead of Pfizer. A few minutes following administration, RPh spoke to guardian and patient regarding error that occurred. Both parties were understanding of error. RPh said he would follow up with next step for the patient's second dose.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Undiluted Pediatric Pfizer vaccine was accidently given at 0.2 ml to patient.  Advised parents to watch for potential for local and systemic adverse event
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Culture urine, Diarrhoea, Dysstasia, Fatigue
Clinical narrative: In the evening following the vaccine, patient began to run a low grade temp of about 99 (normal is 97.6).  Fatigue and muscle weakness began and continued into the next day.  Tuesday she started having diarrhea and some time after 4:00 pm. she got up to go to the bathroom and passed out on the bathroom floor where she laid for about 12-15 hours.  She was so fatigued she was unable to get up off the floor and she was unable to use her catheter.  She was found by a relative who called an ambulance.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness, Muscular weakness
Clinical narrative: In the evening following the vaccine, patient began to run a low grade temp of about 99 (normal is 97.6).  Fatigue and muscle weakness began and continued into the next day.  Tuesday she started having diarrhea and some time after 4:00 pm. she got up to go to the bathroom and passed out on the bathroom floor where she laid for about 12-15 hours.  She was so fatigued she was unable to get up off the floor and she was unable to use her catheter.  She was found by a relative who called an ambulance.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Feeling hot, Nausea, Paraesthesia
Clinical narrative: pt had dizziness, nausea and warm feeling and tingling in her hands.  The dizziness and nausea occurred about 10 minutes after administration and seemed to get worse and the warm feeling and tingling occurred. We gave sips of water as she had dry mouth and placed cold compress on forehead, we contacted 911 and they decided to come and did go ahead and take her vitals, she refused to go with emts and seemed to be okay
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous
Clinical narrative: red rash all over body, itchy, goes away with antihistamines but will come back after stoppage of said antihistamines, reacts to heat and pressure on skin
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Blood creatine increased, Blood urea increased, Dyspnoea
Clinical narrative: After the vaccine I had systemic swelling that is unusual for me. I had constant associated palpitations X 3 days, SOB, generalized weakness and anxiety. I felt awful Saturday and went to the ER. At the ER, my vitals were as follows: Blood Pressure 172/107 Pulse 107 Oxygen Saturation 97% RR 22
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Palpitations, Swelling
Clinical narrative: After the vaccine I had systemic swelling that is unusual for me. I had constant associated palpitations X 3 days, SOB, generalized weakness and anxiety. I felt awful Saturday and went to the ER. At the ER, my vitals were as follows: Blood Pressure 172/107 Pulse 107 Oxygen Saturation 97% RR 22
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anal incontinence, Arteriovenous fistula site pseudoaneurysm, Asthenia, Blood creatinine, Blood potassium
Clinical narrative: Hospitalized (1.21 - 1.27.22); COVID-19 positive (1.20.22); Fully vaccinated (no booster) Date of Admission: 1/21/2022, Hospital Day: 7 Date of Discharge: 1/27/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] HOSPITAL COURSE: The patient is a 54 yo woman with ESRD on HD with recent repair of bleeding pseudoaneurysm AV fistula, diastolic HF, hypertension, vascular dementia, hx of CVA with residual left sided weakness who presented to ED with lethargy, confusion and generalized weakness. Over the 3 days PTA patient had been feeling down and weaker with decreased appetite. She vomitted at HD on 1/20 and was subsequently found to be COVID positive. On day of admission, she was difficult to awaken from sleep and did have fecal incontinence. She did become more alert and was alert and oriented by the time she was seen in ED. Vitals were WNL at admission. Labs showed Cr consistent with ESRD but otherwise no abnormalities. Nephrology was consulted for HD needs. She had no oxygen needs. Her home diuretics were held in the setting of dehydration.  Her stay was remarkable for spontaneous recovery, hemodialysis and discharge home 1/27/22 with improvement of her oral intake. Care was discussed with her significant other per patient request and questions and concerns addressed.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Confusional state, Cough, Decreased appetite, Dehydration
Clinical narrative: Hospitalized (1.21 - 1.27.22); COVID-19 positive (1.20.22); Fully vaccinated (no booster) Date of Admission: 1/21/2022, Hospital Day: 7 Date of Discharge: 1/27/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] HOSPITAL COURSE: The patient is a 54 yo woman with ESRD on HD with recent repair of bleeding pseudoaneurysm AV fistula, diastolic HF, hypertension, vascular dementia, hx of CVA with residual left sided weakness who presented to ED with lethargy, confusion and generalized weakness. Over the 3 days PTA patient had been feeling down and weaker with decreased appetite. She vomitted at HD on 1/20 and was subsequently found to be COVID positive. On day of admission, she was difficult to awaken from sleep and did have fecal incontinence. She did become more alert and was alert and oriented by the time she was seen in ED. Vitals were WNL at admission. Labs showed Cr consistent with ESRD but otherwise no abnormalities. Nephrology was consulted for HD needs. She had no oxygen needs. Her home diuretics were held in the setting of dehydration.  Her stay was remarkable for spontaneous recovery, hemodialysis and discharge home 1/27/22 with improvement of her oral intake. Care was discussed with her significant other per patient request and questions and concerns addressed.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Depressed mood, Haemodialysis, Laboratory test, Lethargy, Limb injury
Clinical narrative: Hospitalized (1.21 - 1.27.22); COVID-19 positive (1.20.22); Fully vaccinated (no booster) Date of Admission: 1/21/2022, Hospital Day: 7 Date of Discharge: 1/27/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] HOSPITAL COURSE: The patient is a 54 yo woman with ESRD on HD with recent repair of bleeding pseudoaneurysm AV fistula, diastolic HF, hypertension, vascular dementia, hx of CVA with residual left sided weakness who presented to ED with lethargy, confusion and generalized weakness. Over the 3 days PTA patient had been feeling down and weaker with decreased appetite. She vomitted at HD on 1/20 and was subsequently found to be COVID positive. On day of admission, she was difficult to awaken from sleep and did have fecal incontinence. She did become more alert and was alert and oriented by the time she was seen in ED. Vitals were WNL at admission. Labs showed Cr consistent with ESRD but otherwise no abnormalities. Nephrology was consulted for HD needs. She had no oxygen needs. Her home diuretics were held in the setting of dehydration.  Her stay was remarkable for spontaneous recovery, hemodialysis and discharge home 1/27/22 with improvement of her oral intake. Care was discussed with her significant other per patient request and questions and concerns addressed.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Somnolence, Vomiting
Clinical narrative: Hospitalized (1.21 - 1.27.22); COVID-19 positive (1.20.22); Fully vaccinated (no booster) Date of Admission: 1/21/2022, Hospital Day: 7 Date of Discharge: 1/27/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] HOSPITAL COURSE: The patient is a 54 yo woman with ESRD on HD with recent repair of bleeding pseudoaneurysm AV fistula, diastolic HF, hypertension, vascular dementia, hx of CVA with residual left sided weakness who presented to ED with lethargy, confusion and generalized weakness. Over the 3 days PTA patient had been feeling down and weaker with decreased appetite. She vomitted at HD on 1/20 and was subsequently found to be COVID positive. On day of admission, she was difficult to awaken from sleep and did have fecal incontinence. She did become more alert and was alert and oriented by the time she was seen in ED. Vitals were WNL at admission. Labs showed Cr consistent with ESRD but otherwise no abnormalities. Nephrology was consulted for HD needs. She had no oxygen needs. Her home diuretics were held in the setting of dehydration.  Her stay was remarkable for spontaneous recovery, hemodialysis and discharge home 1/27/22 with improvement of her oral intake. Care was discussed with her significant other per patient request and questions and concerns addressed.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: undiluted Pediatric Pfizer was administered to patient at 0.2 ml .  Advised parents of potential for local and systemic adverse events
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test normal, Burning sensation, Carpal tunnel syndrome, Chest X-ray normal
Clinical narrative: June 7, 2021 - ER hospital, - Two weeks after cleared to get off of Bactrim, I was attacked by something.  Had Tingling/burning all over body both sides - arms, legs back, stomach, vagina, etc.  Pain was centralized in lower back (never had lower back problems).  I had swollen and painful lymph nodes in left arm.  Headaches.  Exhaustion.  Kept telling them it was like I had internal shingles all over my body.  Covid test was negative.  Chest Xray and bloodwork all negative.  Sent me home with more antibiotics and medicine for a urinary tract infection which I didn't have.  Extensive bloodwork was taken to rule out any Staph infection.   June 16, 2021 - ER hospital - Returned to ER more lethargic and exhausted.  Now running elevated temp in evenings 99.3-100.0.  Burning pain all over continued.  Told me to go to a Neurologist and basically you're not dying.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Lethargy, Lymph node pain, Lymphadenopathy
Clinical narrative: June 7, 2021 - ER hospital, - Two weeks after cleared to get off of Bactrim, I was attacked by something.  Had Tingling/burning all over body both sides - arms, legs back, stomach, vagina, etc.  Pain was centralized in lower back (never had lower back problems).  I had swollen and painful lymph nodes in left arm.  Headaches.  Exhaustion.  Kept telling them it was like I had internal shingles all over my body.  Covid test was negative.  Chest Xray and bloodwork all negative.  Sent me home with more antibiotics and medicine for a urinary tract infection which I didn't have.  Extensive bloodwork was taken to rule out any Staph infection.   June 16, 2021 - ER hospital - Returned to ER more lethargic and exhausted.  Now running elevated temp in evenings 99.3-100.0.  Burning pain all over continued.  Told me to go to a Neurologist and basically you're not dying.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging normal, Myelitis transverse, Nerve conduction studies, Paraesthesia, SARS-CoV-2 test negative
Clinical narrative: June 7, 2021 - ER hospital, - Two weeks after cleared to get off of Bactrim, I was attacked by something.  Had Tingling/burning all over body both sides - arms, legs back, stomach, vagina, etc.  Pain was centralized in lower back (never had lower back problems).  I had swollen and painful lymph nodes in left arm.  Headaches.  Exhaustion.  Kept telling them it was like I had internal shingles all over my body.  Covid test was negative.  Chest Xray and bloodwork all negative.  Sent me home with more antibiotics and medicine for a urinary tract infection which I didn't have.  Extensive bloodwork was taken to rule out any Staph infection.   June 16, 2021 - ER hospital - Returned to ER more lethargic and exhausted.  Now running elevated temp in evenings 99.3-100.0.  Burning pain all over continued.  Told me to go to a Neurologist and basically you're not dying.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Hemiparesis, Magnetic resonance imaging abnormal, Multiple sclerosis, Paraesthesia
Clinical narrative: Developed MS lesions within a month of getting second dose. I had three active lesions causing parathesis on left side and weakness on right side. I had no MS symptoms before the vaccine, but have had at least 12 lesions since. Could be just a coincidence though.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: I began noticing a sudden hair loss in October, 2021.  I continue to experience hair loss. My thyroid TSH was sufficient upon onset, and continues to remain sufficient.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: patient hospitalized
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: forgot to dilute vial before administering 0.2 ml  IM once to patient. Advised parents of potential for local and systemic adverse events
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time normal, Acute respiratory failure, COVID-19, COVID-19 pneumonia, International normalised ratio normal
Clinical narrative: Hospitalized (1.23.22-1.27.22); COVID-19 positive (1.23.22); Fully Vaccinated Patient is a 10 y.o. old male admitted for COVID-19 infection. Admission Date: 1/23/2022  Discharge Date: 1/27/2022 DETAILS OF HOSPITAL STAY: Severe sepsis [A41.9, R65.20] Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 10 y.o. male with congenital glycosylation mutation, global developmental delay with GT dependency, epilepsy on antiepileptics, moderate persistent asthma, CKD, OSA, and neutropenia/lymphopenia with viral infections who is admitted with COVID-19 pneumonia complicated by neutropenia, lymphopenia, and transaminitis. Patient did not require increased oxygen support from his baseline (2L when sleeping), however, given his history of neutropenia and concerning picture for bacterial pneumonia he was started on IV Cefepime.  Given his transaminitis, neutropenia, and risk for thrombosis with his genetic condition and COVID pneumonia and non ambulatory state, Heme/Onc was consulted. They recommended no anticoagulation given his PT/PTT/INR were high normal. Zarxio was started on 1/25 given his neutrophils trending down (calculated on Mandiff 600). His ANC improved >1000 after one day for which his cefepime was discontinued. ID consulted and stated he is not a candidate for IV Remdesivir or decadron given his respiratory stability.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lymphopenia, Neutropenia, Neutrophil count decreased, Prothrombin time normal, Respiratory disorder
Clinical narrative: Hospitalized (1.23.22-1.27.22); COVID-19 positive (1.23.22); Fully Vaccinated Patient is a 10 y.o. old male admitted for COVID-19 infection. Admission Date: 1/23/2022  Discharge Date: 1/27/2022 DETAILS OF HOSPITAL STAY: Severe sepsis [A41.9, R65.20] Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 10 y.o. male with congenital glycosylation mutation, global developmental delay with GT dependency, epilepsy on antiepileptics, moderate persistent asthma, CKD, OSA, and neutropenia/lymphopenia with viral infections who is admitted with COVID-19 pneumonia complicated by neutropenia, lymphopenia, and transaminitis. Patient did not require increased oxygen support from his baseline (2L when sleeping), however, given his history of neutropenia and concerning picture for bacterial pneumonia he was started on IV Cefepime.  Given his transaminitis, neutropenia, and risk for thrombosis with his genetic condition and COVID pneumonia and non ambulatory state, Heme/Onc was consulted. They recommended no anticoagulation given his PT/PTT/INR were high normal. Zarxio was started on 1/25 given his neutrophils trending down (calculated on Mandiff 600). His ANC improved >1000 after one day for which his cefepime was discontinued. ID consulted and stated he is not a candidate for IV Remdesivir or decadron given his respiratory stability.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Transaminases
Clinical narrative: Hospitalized (1.23.22-1.27.22); COVID-19 positive (1.23.22); Fully Vaccinated Patient is a 10 y.o. old male admitted for COVID-19 infection. Admission Date: 1/23/2022  Discharge Date: 1/27/2022 DETAILS OF HOSPITAL STAY: Severe sepsis [A41.9, R65.20] Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 10 y.o. male with congenital glycosylation mutation, global developmental delay with GT dependency, epilepsy on antiepileptics, moderate persistent asthma, CKD, OSA, and neutropenia/lymphopenia with viral infections who is admitted with COVID-19 pneumonia complicated by neutropenia, lymphopenia, and transaminitis. Patient did not require increased oxygen support from his baseline (2L when sleeping), however, given his history of neutropenia and concerning picture for bacterial pneumonia he was started on IV Cefepime.  Given his transaminitis, neutropenia, and risk for thrombosis with his genetic condition and COVID pneumonia and non ambulatory state, Heme/Onc was consulted. They recommended no anticoagulation given his PT/PTT/INR were high normal. Zarxio was started on 1/25 given his neutrophils trending down (calculated on Mandiff 600). His ANC improved >1000 after one day for which his cefepime was discontinued. ID consulted and stated he is not a candidate for IV Remdesivir or decadron given his respiratory stability.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Three doses of Moderna vaccine were given to case under 18 years old. Other two vaccines:  Moderna  025B21A  Administration date : 04/08/2021  Moderna  009C21A  Administration date :5/11/2021
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles - left side of face that caused a very bad ophthalmic infection. 4 weeks in I?m still recovering
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Acute sinusitis, Breath odour, C-reactive protein increased, COVID-19
Clinical narrative: Hospitalized (1.23.22 - 1.29.22);  COVID-19 positive (1.18.22); Fully vaccinated  Admission Date: 1/23/2022  Discharge Date: 01/29/2022 DETAILS OF HOSPITAL STAY: Acute hypoxemic respiratory failure due to COVID-19  [U07.1, J96.01] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute respiratory failure due to COVID-19 [U07.1, J96.00]   HOSPITAL COURSE: Patient is a 10 y.o. male with PMHx complex partial epilepsy, GDD, Dysphagia, Spastic CP, G-tube dependence who was admitted for admitted for acute hypoxic respiratory failure secondary to COVID Pneumonia.  Patient presented to ED on 1/23 following a 3-day history of worsening cough. Patient had been unwell since 1/15 when he developed terrible nasal congestion. He was seen by his PCP on 1/18 who diagnosed him with acute bacterial rhinosinusitis and started him on a 10-day course of Omnicef and Culturelle. He also tested positive for COVID-19 at that time. 2-3days prior to admission, he then developed a productive cough for which his PCP started him on Albuterol. Patient did not seem to improve with albuterol. Additionally, mom also noted that he had low SpO2 on home pulse ox and so he was brought in to the ED for further evaluation. In the ED, patient was hypothermic and hypoxic (SpO2 87%). He was placed in a heating blanket and started on 4L NC. Labs notable for CRP 15, ESR 19, Procal 0.08. CBC, UA wnl. CXR notable for perihilar opacities. He received 2x NS boluses and 1x albuterol and was then admitted to the inpatient service.  While admitted to the floor, the patient was started on Decadron for his COVID pna, with Pepcid for GI prophylaxis. He had an AWARE called overnight due to increased WOB for which he was started on HFNC and then transferred to the PICU. While in the PICU, his respiratory support was escalated to NIPPV. He also had Albuterol, HTS and Chest physiotherapy added to his pulmonary regimen. He completed his Omnicef course on 1/26. He was eventually weaned off NIPPV to CPAP on 1/27, and then weaned to NC later that day. Patient was then transferred back to the floors on room air. For the rest of his admission, patient remained clinically stable and was on room air. His pulmonary medication regimen was simplified to Albuterol 2.5mg with chest percussion q6h. Shared decision making was made between family and treatment team who agreed that the patient can be discharged home with albuterol and manual CPT q6-8hrs for the next 2-3days. Patient discharged home in stable condition.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Cough, Drooling, Dysphonia
Clinical narrative: Hospitalized (1.23.22 - 1.29.22);  COVID-19 positive (1.18.22); Fully vaccinated  Admission Date: 1/23/2022  Discharge Date: 01/29/2022 DETAILS OF HOSPITAL STAY: Acute hypoxemic respiratory failure due to COVID-19  [U07.1, J96.01] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute respiratory failure due to COVID-19 [U07.1, J96.00]   HOSPITAL COURSE: Patient is a 10 y.o. male with PMHx complex partial epilepsy, GDD, Dysphagia, Spastic CP, G-tube dependence who was admitted for admitted for acute hypoxic respiratory failure secondary to COVID Pneumonia.  Patient presented to ED on 1/23 following a 3-day history of worsening cough. Patient had been unwell since 1/15 when he developed terrible nasal congestion. He was seen by his PCP on 1/18 who diagnosed him with acute bacterial rhinosinusitis and started him on a 10-day course of Omnicef and Culturelle. He also tested positive for COVID-19 at that time. 2-3days prior to admission, he then developed a productive cough for which his PCP started him on Albuterol. Patient did not seem to improve with albuterol. Additionally, mom also noted that he had low SpO2 on home pulse ox and so he was brought in to the ED for further evaluation. In the ED, patient was hypothermic and hypoxic (SpO2 87%). He was placed in a heating blanket and started on 4L NC. Labs notable for CRP 15, ESR 19, Procal 0.08. CBC, UA wnl. CXR notable for perihilar opacities. He received 2x NS boluses and 1x albuterol and was then admitted to the inpatient service.  While admitted to the floor, the patient was started on Decadron for his COVID pna, with Pepcid for GI prophylaxis. He had an AWARE called overnight due to increased WOB for which he was started on HFNC and then transferred to the PICU. While in the PICU, his respiratory support was escalated to NIPPV. He also had Albuterol, HTS and Chest physiotherapy added to his pulmonary regimen. He completed his Omnicef course on 1/26. He was eventually weaned off NIPPV to CPAP on 1/27, and then weaned to NC later that day. Patient was then transferred back to the floors on room air. For the rest of his admission, patient remained clinically stable and was on room air. His pulmonary medication regimen was simplified to Albuterol 2.5mg with chest percussion q6h. Shared decision making was made between family and treatment team who agreed that the patient can be discharged home with albuterol and manual CPT q6-8hrs for the next 2-3days. Patient discharged home in stable condition.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Eye discharge, Feeling abnormal, Full blood count normal, Hypothermia
Clinical narrative: Hospitalized (1.23.22 - 1.29.22);  COVID-19 positive (1.18.22); Fully vaccinated  Admission Date: 1/23/2022  Discharge Date: 01/29/2022 DETAILS OF HOSPITAL STAY: Acute hypoxemic respiratory failure due to COVID-19  [U07.1, J96.01] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute respiratory failure due to COVID-19 [U07.1, J96.00]   HOSPITAL COURSE: Patient is a 10 y.o. male with PMHx complex partial epilepsy, GDD, Dysphagia, Spastic CP, G-tube dependence who was admitted for admitted for acute hypoxic respiratory failure secondary to COVID Pneumonia.  Patient presented to ED on 1/23 following a 3-day history of worsening cough. Patient had been unwell since 1/15 when he developed terrible nasal congestion. He was seen by his PCP on 1/18 who diagnosed him with acute bacterial rhinosinusitis and started him on a 10-day course of Omnicef and Culturelle. He also tested positive for COVID-19 at that time. 2-3days prior to admission, he then developed a productive cough for which his PCP started him on Albuterol. Patient did not seem to improve with albuterol. Additionally, mom also noted that he had low SpO2 on home pulse ox and so he was brought in to the ED for further evaluation. In the ED, patient was hypothermic and hypoxic (SpO2 87%). He was placed in a heating blanket and started on 4L NC. Labs notable for CRP 15, ESR 19, Procal 0.08. CBC, UA wnl. CXR notable for perihilar opacities. He received 2x NS boluses and 1x albuterol and was then admitted to the inpatient service.  While admitted to the floor, the patient was started on Decadron for his COVID pna, with Pepcid for GI prophylaxis. He had an AWARE called overnight due to increased WOB for which he was started on HFNC and then transferred to the PICU. While in the PICU, his respiratory support was escalated to NIPPV. He also had Albuterol, HTS and Chest physiotherapy added to his pulmonary regimen. He completed his Omnicef course on 1/26. He was eventually weaned off NIPPV to CPAP on 1/27, and then weaned to NC later that day. Patient was then transferred back to the floors on room air. For the rest of his admission, patient remained clinically stable and was on room air. His pulmonary medication regimen was simplified to Albuterol 2.5mg with chest percussion q6h. Shared decision making was made between family and treatment team who agreed that the patient can be discharged home with albuterol and manual CPT q6-8hrs for the next 2-3days. Patient discharged home in stable condition.